Managing Your Risk In the Safe Transportation of Life-saving Pharmaceuticals – Active Versus Passive in the Distribution Supply Chain
The growth in demand for biologics and preventative medicines will only lead to further increases in the amount of temperature-sensitive products moving though the global supply chains. Today, 25 per cent of all healthcare products are temperature-sensitive and the requirements for high-value, lifesaving healthcare products such as blood plasma, insulin, vaccines and other biological pharmaceuticals are at an all-time high. Kavita Somaroo at DS Smith Plastics Cool Logistics discusses one of the most prominent challenges faced by the pharmaceutical industry in the safe transportation of temperature- controlled pharmaceutical products.
http://jforcs.com/jcs/wp-content/uploads/2013/02/1.Managing-Your-Risk-In-The-Safe.pdf